The Health Protection (Coronavirus, International Travel and Operator Liability) (Wales) (Miscellaneous Amendments) (No. 4) Regulations 2021

Amendments to Schedule 1C

7.—(1) Schedule 1C (mandatory testing after arrival in Wales) is amended as follows.

(2) In sub-paragraph (b)(ii) of paragraph 1 (day 2 test requirements)—

(a) after “greater than” insert “or equal to”;

(b) for “with” substitute “or”.

(3) For paragraph 2 (day 8 test requirements) substitute—

“Day 8 test requirements

2.   A day 8 test complies with this sub-paragraph where—

(a) it is a semi-quantitative test for the detection of coronavirus which—

(i) targets a minimum of two distinguishable SARS-CoV-2 genes other than the S gene and performance reference controls,

(ii) includes routine in silico assurance against every variant of concern, and

(iii) produces a test solution that provides extracted nucleic acid that is suitable for whole genome sequencing using a specified method,

(b) the manufacturer of any device used for the purposes of the test states that the device—

(i) uses an established molecular detection method,

(ii) has a specificity greater than or equal to 97% (or a 95% two-sided confidence interval entirely above 95%),

(iii) has a sensitivity greater than or equal to 95% (or a 95% two-sided confidence interval entirely above 90%),

(iv) has a limit of detection of less than or equal to 1000 SARS-CoV-2 copies per millilitre, and

(v) is suitable for identifying every variant of concern, and

(c) any device used for the purposes of the test—

(i) can be put into service in accordance with Part 4 of the Medical Devices Regulations 2002(1), other than solely by virtue of regulation 39(2) of those Regulations, and

(ii) has been validated no more than 18 months before the test is administered or provided to P.”

(1)

S.I. 2002/618.